Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetics and epigenetics of NAFLD and NASH: Clinical impact
Mohammed Eslam, Luca Valenti, Stefano Romeo
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 268-279
Closed Access | Times Cited: 843

Showing 1-25 of 843 citing articles:

Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman, Brent A. Neuschwander‐Tetri, Mary E. Rinella, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 908-922
Open Access | Times Cited: 3354
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam, Philip N. Newsome, Shiv Kumar Sarin, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 1, pp. 202-209
Open Access | Times Cited: 3297
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Mohammed Eslam, Arun J. Sanyal, Jacob George, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1999-2014.e1
Open Access | Times Cited: 2633
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Rohit Loomba, Scott L. Friedman, Gerald I. Shulman
Cell (2021) Vol. 184, Iss. 10, pp. 2537-2564
Open Access | Times Cited: 1292
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui, et al.
Hepatology (2023) Vol. 77, Iss. 5, pp. 1797-1835
Open Access | Times Cited: 1191
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
Ian J. Neeland, Robert Ross, Jean‐Pierre Després, et al.
The Lancet Diabetes & Endocrinology (2019) Vol. 7, Iss. 9, pp. 715-725
Open Access | Times Cited: 1020
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Pοlyzos, Јannis Kountouras, Christos S. Mantzoros
Metabolism (2018) Vol. 92, pp. 82-97
Closed Access | Times Cited: 961
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2018) Vol. 65, pp. 37-55
Open Access | Times Cited: 901
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies
Norbert Stefan, Hans‐Ulrich Häring, Kenneth Cusi
The Lancet Diabetes & Endocrinology (2018) Vol. 7, Iss. 4, pp. 313-324
Closed Access | Times Cited: 741
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
Qing Ye, Biyao Zou, Yee Hui Yeo, et al.
˜The œLancet. Gastroenterology & hepatology (2020) Vol. 5, Iss. 8, pp. 739-752
Closed Access | Times Cited: 704
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
Mohammed Eslam, Shiv Kumar Sarin, Vincent Wai–Sun Wong, et al.
Hepatology International (2020) Vol. 14, Iss. 6, pp. 889-919
Open Access | Times Cited: 652
Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages
Smitha Krishnan, Yufang Ding, Nima Saedi, et al.
Cell Reports (2018) Vol. 23, Iss. 4, pp. 1099-1111
Open Access | Times Cited: 519
NAFLD and cardiovascular diseases: a clinical review
Philipp Kasper, Anna Martin, Sonja Lang, et al.
Clinical Research in Cardiology (2020) Vol. 110, Iss. 7, pp. 921-937
Open Access | Times Cited: 470
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Ralf Weiskirchen, Sabine Weiskirchen, Frank Tacke
Molecular Aspects of Medicine (2018) Vol. 65, pp. 2-15
Closed Access | Times Cited: 464
Complications, morbidity and mortality of nonalcoholic fatty liver disease
Alessandro Mantovani, Eleonora Scorletti, Antonella Mosca, et al.
Metabolism (2020) Vol. 111, pp. 154170-154170
Open Access | Times Cited: 449
Determinants of fibrosis progression and regression in NASH
Detlef Schuppan, Rambabu Surabattula, Xiaoyu Wang
Journal of Hepatology (2017) Vol. 68, Iss. 2, pp. 238-250
Closed Access | Times Cited: 420
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
Alessandro Mantovani, Alessandro Csermely, Graziana Petracca, et al.
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 11, pp. 903-913
Open Access | Times Cited: 398
Mapping the proteo-genomic convergence of human diseases
Maik Pietzner, Eleanor Wheeler, Julia Carrasco-Zanini, et al.
Science (2021) Vol. 374, Iss. 6569
Open Access | Times Cited: 373
NAFLD as a driver of chronic kidney disease
Christopher D. Byrne, Giovanni Targher
Journal of Hepatology (2020) Vol. 72, Iss. 4, pp. 785-801
Open Access | Times Cited: 351
Update on NAFLD genetics: From new variants to the clinic
Eric Trépo, Luca Valenti
Journal of Hepatology (2020) Vol. 72, Iss. 6, pp. 1196-1209
Open Access | Times Cited: 318
Role of Insulin Resistance in MAFLD
Yoshitaka Sakurai, Naoto Kubota, Toshimasa Yamauchi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4156-4156
Open Access | Times Cited: 284
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
Mohammed Eslam, Jacob George
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 1, pp. 40-52
Closed Access | Times Cited: 270
What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’
Yasser Fouad, Imam Waked, Steven Bollipo, et al.
Liver International (2020) Vol. 40, Iss. 6, pp. 1254-1261
Open Access | Times Cited: 269
NAFLD in children: new genes, new diagnostic modalities and new drugs
Valério Nobili, Anna Alisi, Luca Valenti, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 9, pp. 517-530
Closed Access | Times Cited: 261
Therapeutic pipeline in nonalcoholic steatohepatitis
Raj Vuppalanchi, Mazen Noureddin, Naim Alkhouri, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 6, pp. 373-392
Closed Access | Times Cited: 234
Page 1 - Next Page

Scroll to top